Gilead Sciences reported $2.6B in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Agios Pharmaceuticals AGIO:US USD 5.18M 1.12M
ALKERMES ALKS:US USD 166.3M 10.69M
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Amgen AMGN:US USD 4.76B 203M
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Coherus Biosciences CHRS:US USD 27.72M 4.02M
Eli Lilly And LLY:US USD 3.83B 68.3M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Moderna Inc MRNA:US USD 2.08B 156M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novartis NOVN:VX USD 6.78B 101M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Puma Biotechnology PBYI:US USD 5.45M 1.21M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
United Therapeutics UTHR:US USD 91M 1.1M
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M
YTE INCY:US USD 45.87M 8.63M